Through this study we aim to compare the effect of preoperative intranasal dexmedetomidine and lignocaine spray in attenuation of haemodynamic responses to laryngoscopy for endotracheal intubation in patients undergoing elective surgeries. Patients planned for elective surgeries who are willing to participate and meets inclusion criteria will be enrolled for the study. An informed consent will be obtained from patients preoperatively using an information sheet. Participants of the study will be divided into two groups by computer generated block randomization. Group A will receive a 1mcg per kg of intranasal dexmedetomidine with atomizing device of company MAD Nasal Intranasal Mucosal Atomization Device 30 minutes prior to induction in holding bay. Group B will receive 1.5mg per kg of 10 percent lignocaine spray prior to induction onto the oropharyngeal mucosa with atomization device. Both groups will receive normal saline placebo at the respective time. All patients will have standard ASA monitoring with peripheral intravenous access. General anaesthesia will be administered as per standard institutional protocols. Induction will be done with propofol 1 to 2mg per kg, Fentanyl 1 to 2mcg per kg and titrated to effect to maintain haemodynamics, Atracurium 0.5mg per kg.  Anaesthesia will be maintained with a MAC of 0.7 to 0.8 of isoflurane. Unanticipated difficult airway, Intubation time, number of attempts, haemodynamic response to scopy  as Heart rate and Blood Pressure at baseline, 2 ,5 and 10 min post tracheal intubation to be noted. Any bradycardia, hypotension, tachycardia or hypertension greater than 20 percent will be treated as per standard guidelines. Incidence of sore throat post surgery will be documented.